Abstract
Colorectal cancer is the third most common type of cancer diagnosed in United States, and with rectal cancer accounting for approximately the 30% of the cases. In 2016, the American Cancer Society estimated almost 40,000 of new rectal cancer cases, the majority undergoing surgery – a surgery that has traditionally been difficult, especially in cases of obesity, males and with narrow pelvis. The oncologic cornerstone of this surgery is the removal of the mesorectum as an intact specimen en-bloc with a margin-free tumour. Systematic adherence to this principle has been proven to prolong survival and reduce locoregional recurrence.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc. 2010;24:1205–10.
Buess G, Kipfmüller K, Hack D, et al. Technique of transanal endoscopic microsurgery. Surg Endosc. 1988;2(2):71–5.
Marks GJ, Marks JH, Mohiuddin M, et al. Radical sphincter preservation surgery with coloanal anastomosis following high-dose external irradiation for the very low lying rectal cancer. Recent Results Cancer Res. 1998;146:161–74.
Whiteford MH, Denk PM, Swanstrom LL. Feasibility of radical sigmoid colectomy performed as natural orifice translumenal endoscopic surgery (NOTES) using transanal endoscopic microsurgery. Surg Endosc. 2007;21:1870–4.
Atallah S, Larach S, Albert M. Transanal minimally invasive surgery: a giant leap forward. Surg Endosc. 2010;24:2200–5.
Heald RJ. A new approach to rectal cancer. Br J Hosp Med. 1979;22:277–28.
Green BL, Marshall HC, Collinson F, et al. Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer. Br J Surg. 2013;100(1):75–82.
Guillou PJ, Quirke P, Thorpe H, et al. MRC CLASICC trial group. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365(9472):1718–26.
van der Pas MH, Haglind E, Cuesta MA, et al. COlorectal cancer Laparoscopic or Open Resection II (COLOR II) Study Group. Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial. Lancet Oncol. 2013;14(3):210–8.
Kang SB, Park JW, Jeong SY, et al. Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol. 2010;11:637–45.
Kim JS, Cho SY, Min BS, et al. Risk factors for anastomotic leakage after laparoscopic intracorporeal colorectal anastomosis with a double stapling technique. J Am Coll Surg. 2009;209(6):694–701.
Schiessel R, Karner-Hanusch J, Herbst F, et al. Intersphincteric resection for low rectal tumours. Br J Surg. 1994;81(9):1376–8.
Akagi Y, Shirouzu K, Ogata Y, et al. Oncologic outcomes of intersphincteric resection without preoperative chemoradiotherapy for very low rectal cancer. Surg Oncol. 2013;22(2):144–9.
Marks G, Mohiuddin M, Goldstein SD. Sphincter preservation for cancer of the distal rectum using high dose preoperative radiation. Int J Radiat Oncol Biol Phys. 1988;15(5):1065–8.
Tasende MM, Delgado S, Jimenez M, et al. Minimal invasive surgery: NOSE and NOTES in ulcerative colitis. Surg Endosc. 2015;29:3313–8.
Bravo R, Fernández-Hevia M, Jiménez-Toscano M, et al. Transanal Hartmann reversal: a new technique. Surg Endosc. 2016;30(6):2628–31.
Borstlap WA, Harran N, Tanis PJ, Bemelman WA. Feasibility of the TAMIS technique for redo pelvic surgery. Surg Endosc. 2016;30(12):5364–71.
Jafari MD, Wexner SD, Martz JE, et al. Perfusion assessment in laparoscopic left-sided/anterior resection (PILLAR II): a multi-institutional study. J Am Coll Surg. 2015;220(1):82–92.
Rouanet P, Mourregot A, Azar CC, et al. Transanal endoscopic proctectomy: an innovative procedure for difficult resection of rectal tumors in men with narrow pelvis. Dis Colon Rectum. 2013;56:408–15.
Simillis C, Hompes R, Penna M, et al. A systematic review of transanal total mesorectal excision: is this the future of rectal cancer surgery? Color Dis. 2016;18(1):19–36.
Velthuis S, Veltcamp Helbach M, Tuynman JB, et al. Intra-abdominal bacterial contamination in TAMIS total mesorectal excision for rectal carcinoma: a prospective study. Surg Endosc. 2015;29(11):3319–23.
Nagtegaal ID, van de Velde CJH, van der Worp E, et al. Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol. 2002;20:1729–37.
Tuech JJ, Karoui M, Lelong B, et al. A step toward NOTES total mesorectal excision for rectal cancer. Endoscopic transanal proctectomy. Ann Surg. 2015;261:228–33.
Veltcamp Helbach M, Deijen CL, Velthuis S, et al. Transanal total mesorectal excision for rectal adenocarcinoma: short-term outcomes and experience after 80 cases. Surg Endosc. 2016;30(2):464–70.
Lacy AM, Tasende MM, Delgado S, et al. Transanal total mesorectal excision for rectal cancer: outcome after 140 patients. J Am Coll Surg. 2015;221(2):415–23.
Elmore U, Fumagalli Romario U, Vignali A, et al. Laparoscopic anterior resection with transanal total mesorectal excision for rectal cancer: preliminary experience and impact on postoperative bowel function. J Laparoendosc Adv Surg Tech A. 2015;25(5):364–9.
Zhang H, Zhang YS, Jin XW, et al. Transanal single-port laparoscopic total mesorectal excision in the treatment of rectal cancer. Tech Coloproctol. 2013;17:117–23.
Chouillard E, Chahine E, Khoury G, et al. Notes total mesorectal excision (TME) for patients with rectal neoplasia: a preliminary experience. Surg Endosc. 2014;28:3150–7.
Leroy J, Barry BD, Melani A, et al. No-scar transanal total mesorectal excision: the last step to pure NOTES for colorectal surgery. JAMA Surg. 2013;148:226–30; discussion 31.
Collinson FJ, Jayne DG, Pigazzi A, et al. An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer. Int J Color Dis. 2012;27(2):233–41.
Huscher CG, Bretagnol F, Ponzano C. Robotic-assisted transanal total mesorectal excision: the key against the Achilles’ heel of rectal cancer. Ann Surg. 2015;261(5):e120–1.
Gómez Ruiz M, Parra IM, Palanzuelos CM, et al. Robotic-assisted laparoscopic transanal total mesorectal excision for rectal cancer: a prospective pilot study. Dis Colon Rectum. 2015;58(1):145–53.
Atallah S, Nassif G, Polavarapu H, et al. Robotic-assisted transanal surgery for total mesorectal excision (RATS-TME): a description of a novel surgical approach with video demonstration. Tech Coloproctol. 2013;17(4):441–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Arroyave, M.C., de Lacy, F.B., Lacy, A.M. (2019). Reverse TME: The “Bottom-UP” Approach to Low Rectal Cancer. In: Kwaan, M., Zbar, A. (eds) Comprehensive Rectal Cancer Care. Springer, Cham. https://doi.org/10.1007/978-3-319-98902-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-98902-0_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98901-3
Online ISBN: 978-3-319-98902-0
eBook Packages: MedicineMedicine (R0)